Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
In chronic disease
a) Up to 80% of GFR may be lost with few changes in functioning of body
b) Remaining nephrons hypertrophy (get bigger) to compensate
c) End result is a systemic disease involving every organ
d) Leading causes of ESRD
a. Diabetes
b. Hypertension
Urinary system
a) Polyuria
i. Results from inability of kidneys to concentrate urine
ii. Occurs most often at night
iii. Specific gravity fixed around 1.010…can’t adjust, can’t concentrate or dilate
iv. Inability to concentrate urine
v. Normal = 1.005 – 1.030
Metabolic disturbances
a) Waste product accumulation
b) As GFR ↓, BUN ↑ and serum Creatinine levels ↑
a. Serum Creatinine (end product of the breakdown of muscle) and creatinine clearance are more accurate
indicators of kidney function than BUN…Blood urea (end product of protein breakdown) nitrogen
c) Normal BUN: 5-20mg/dl
Electrolyte/acid–base imbalances
a) Potassium
a. Most serious
b. Normal: 3.5 – 5.0 mEq/L…when it reach 7-8 that’s a fatal level
c. Hyperkalemia
i. Most serious electrolyte disorder in kidney disease
ii. Fatal dysrhythmias
iii. Results from decreased excretion by kidneys
b) Sodium
a. Normal: 135-145 mEq/L
b. May be normal or low
c. Because of impaired excretion, sodium is retained
d. Water is retained
i. Edema
ii. Hypertension
iii. CHF
c) Calcium and phosphate alterations…work in opposite direction
a. Calcium deficit
i. R/T (related to) inability of GI tract to absorb calcium because of decrease in activated Vitamin D
b. Phosphate excess, kidneys can’t excrete
i. R/T (related to) excretion
d) Magnesium alterations – elevation…body can’t get rid of it, kidney can’t excrete it
e) Metabolic acidosis
a. Results from
i. Inability of kidneys to excrete acid load (primary ammonia)…retaining the acid
ii. Defective reabsorption of bicarbonate
Hematologic system
a) Anemia
a. Due to ↓ production of erythropoietin (help produce red blood cell, produces in bone marrow)
i. From ↓ of functioning renal tubular cells
b. These patient will have a decrease of hemoglobin (normal range 12-17 g/dl), and hematocrit
Cardiovascular system
a) Hypertension
b) Heart failure
Gastrointestinal system
Neurologic system
a) Expected as renal failure progresses
a.Attributed to
i. Increased nitrogenous waste products
ii. Electrolyte imbalances
iii. Metabolic acidosis
b) Altered mental ability
c) Decreased ability to concentrate
d) Lethargy
e) Fatigue
f) Seizures
g) Coma
Musculoskeletal system
a) Renal osteodystrophy
a. Syndrome of skeletal changes
b. Result of alterations in calcium and phosphate metabolism
i. Weaken bones, increase fracture risk
Integumentary system
a) Most noticeable change
a. Yellow-gray discoloration of the skin
b. Due to absorption/retention of urinary pigments
b) Pruritus, itching, dry skin, decrease oil and sweat gland activity
c) Uremic frost (Happen when the BUN is very high, pt is refusing dialysis )
d) Dry, pale skin
e) Dry, brittle hair
f) Thin nails
Reproductive system
a) Infertility
b) Experienced by both sexes
c) Decreased libido
d) Low sperm counts
e) Sexual dysfunction
Psychologic changes
a) Personality and behavioral changes
Diagnostic Studies
1. History and physical examination
2. Laboratory tests
a. BUN
b. Serum creatinine
c. Creatinine clearance…24 hr urine collection
d. Serum electrolytes
e. Urinalysis
f. Urine culture, bacteria growing in urine
Drug therapy
Hyperkalemia…bring down the serum K+ level
1. IV insulin (regular)
a. Potassium moves from the extracellular (bloodstream) to intracellular space
b. IV glucose to manage hypoglycemia
2. Sodium polystyrene sulfonate (Kayexalate)
a. Cation-exchange resin
b. Resin in bowel exchanges potassium for sodium, gives body sodium for exchange of potassium
c. Evacuates potassium-rich stool from body
d. Educate patient that diarrhea may occur due to laxative in preparation
e. Given orally or rectally
Hypertension
1. Weight loss
2. Lifestyle changes
3. Diet recommendations
4. low Sodium and fluid restriction
5. Antihypertensive drugs
a) Diuretics
b) β-Adrenergic blockers
c) Calcium channel blockers
d) Angiotensin-converting enzyme (ACE) inhibitors
e) Angiotensin receptor blocker agents
Renal osteodystrophy
1. Phosphate Binders
a. Calcium Carbonate (Tums) and Calcium Acetate (Phos-Lo) ----- Bind phosphate in bowel and
excreted. Have to be taken within thirty minutes or so with meal…bind the phosphate that injested
with their food…30min-1hr when they eat
2. Sevelamer Hydrochloride (Renagel)
a. Lowers cholesterol and LDLs
b. Should be administered with each meal
c. Side effect: Constipation
3. Supplementing vitamin D
a. Calcitriol (Rocaltrol)
Anemia
1. Erythropoietin
a. Epoetin Alfa (Epogen, Procrit)
b. Administered IV or subcutaneously
c. Increased hemoglobin and hematocrit in 2 to 3 weeks
d. Side effect: Hypertension
2. Iron supplements
a. Side effect: Gastric irritation, constipation
b. May make stool dark in color
3. Folic acid supplements
a. Needed for RBC formation
b. Removed by dialysis
Nutritional therapy
Protein restriction
a. 0.6 to 0.8 g/kg body weight/day
Water restriction
a. Intake depends on daily urine output
b. Space fluid throughout the day
c. Fluids are liquid at room temperature…ice cream, sherbet, jello, Popsicle
Sodium restriction
a. Diets vary from 2 to 4 g / day depending on degree of edema and hypertension
b. Patient should be instructed to avoid high-sodium foods
c. Salt substitutes should not be used because they contain potassium chloride
Potassium restriction
a. 2 to 4 g / day
b. High-potassium foods should be avoided
Phosphate restriction
a. 1000 mg/day
b. Foods high in phosphate
c. Dairy products
d. Most foods high in phosphate are also high in calcium
Focus on Dialysis
1. Movement of fluid/molecules across a semipermeable membrane from one compartment to another
2. Used to correct fluid/electrolyte imbalances and to remove waste products in renal failure
3. Two methods of dialysis available
a. Peritoneal dialysis (PD)
b. Hemodialysis (HD)
4. Begun when patient’s uremia can no longer be adequately managed conservatively
5. Initiated when GFR (or creatinine clearance) <15 ml/min
Procedure
1. Two needles placed in fistula or graft
2. Needle closer to fistula or red catheter lumen pulls blood from patient and sends to dialyzer
3. Blood returned from dialyzer to patient through second needle or blue catheter
4. Dialyzer/blood lines primed with saline solution to eliminate air
5. Heparin added to blood as it flows to dialyzer
a. Patient at risk for bleeding
Hemodialysis: Complications